BioNexus Gene Lab Corp
Company Profile
Business description
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
Contact
No.5 Jln Bangsar Utama 1
Unit A-28-7, Level 28, Tower A
Menara UOA Bangsar
Kuala LumpurSGR59200
MYST: +60 3072416898
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 December 2025
Employees
1
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,833.60 | 4.90 | 0.06% |
CAC 40 | 7,754.55 | 16.13 | 0.21% |
DAX 40 | 23,934.13 | 144.02 | 0.61% |
Dow JONES (US) | 44,817.56 | 333.14 | 0.75% |
FTSE 100 | 8,823.20 | 48.51 | 0.55% |
HKSE | 24,069.94 | 151.47 | -0.63% |
NASDAQ | 20,587.79 | 194.66 | 0.95% |
Nikkei 225 | 39,785.90 | 23.42 | 0.06% |
NZX 50 Index | 12,704.48 | 79.81 | -0.62% |
S&P 500 | 6,275.88 | 48.46 | 0.78% |
S&P/ASX 200 | 8,595.80 | 1.90 | -0.02% |
SSE Composite Index | 3,461.15 | 6.36 | 0.18% |